Clinical Trial Update: A Phase I Study to Assess the Safety and Distribution of VB-111 in Patients With Advanced Metastatic Cancer [Phase 1]

View source ↗

Summary

This document summarizes a Phase I clinical trial designed to evaluate the safety and distribution of VB-111 in patients with advanced metastatic cancer.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cancer

Drugs mentioned

• VB-111

Snippet

Sponsor: Vascular Biogenics Ltd. operating as VBL Therapeutics | Conditions: Advanced and/or Metastatic Solid Organ Cancer | Phase 1 | Status: UNKNOWN